Non‐alcoholic fatty liver disease from pathogenesis to management: an update

Non‐alcoholic fatty liver disease from pathogenesis to management: an update

Summary Non‐alcoholic fatty liver disease (NAFLD), the most common chronic liver disease in the Western world, is tightly associated with obesity and metabolic syndrome. NAFLD entails an increased cardiometabolic and liver‐related risk, the latter regarding almost exclusively non‐alcoholic steatohep...

Saved in:

书目详细资料
Main Authors:	Giovanni Musso, Roberto Gambino, Maurizio Cassader
格式:	Revisão
语言:	英语
出版:	2009
在线阅读:	https://doi.org/10.1111/j.1467-789x.2009.00657.x
标签:	添加标签没有标签, 成为第一个标记此记录!

相似书籍

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
由: Giovanni Musso, et al.
出版: (2012)

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
由: Giovanni Musso, et al.
出版: (2012)

Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
由: Giovanni Musso, et al.
出版: (2010)

PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease
由: Giovanni Musso, et al.
出版: (2014)

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
由: Giovanni Musso, et al.
出版: (2010)

Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver
由: Giovanni Musso, et al.
出版: (2013)

Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism
由: Giovanni Musso, et al.
出版: (2013)

Association of obstructive sleep apnoea with the presence and severity of non‐alcoholic fatty liver disease. A systematic review and meta‐analysis
由: Giovanni Musso, et al.
出版: (2013)

Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome?
由: Giovanni Musso, et al.
出版: (2008)

Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities
由: Giovanni Musso, et al.
出版: (2016)

Prolonged saturated fat–induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver
由: Giovanni Musso, et al.
出版: (2009)

Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
由: Giovanni Musso, et al.
出版: (2017)

Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis
由: Musso, Giovanni, et al.
出版: (2017)

Obesity, Diabetes, and Gut Microbiota: The hygiene hypothesis expanded?
由: Musso, Giovanni, et al.
出版: (2010)

Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders
由: Giovanni Musso, et al.
出版: (2010)

Obesity, Diabetes, and Gut Microbiota
由: Giovanni Musso, et al.
出版: (2010)

Polymorphism in microsomal triglyceride transfer protein: A link between liver disease and atherogenic postprandial lipid profile in NASH?
由: Roberto Gambino, et al.
出版: (2007)

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
由: Elisabetta Bugianesi, et al.
出版: (2005)

Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism
由: Musso, Giovanni, et al.
出版: (2013)

Sterol Regulatory Element-Binding Factor 2 (<i>SREBF-2</i>) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism
由: Giovanni Musso, et al.
出版: (2012)

Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
由: Musso, Giovanni, et al.
出版: (2019)

Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
由: Giovanni Musso, et al.
出版: (2018)

A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials
由: Giovanni Musso, et al.
出版: (2011)

Diabetic ketoacidosis with SGLT2 inhibitors
由: Giovanni Musso, et al.
出版: (2020)

Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
由: Giovanni Musso, et al.
出版: (2019)

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
由: Musso, Giovanni, et al.
出版: (2020)

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
由: Giovanni Musso, et al.
出版: (2020)

Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution
由: Giovanni Musso, et al.
出版: (2018)

Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism
由: Giovanni Musso, et al.
出版: (2012)

Transcription factor 7–like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH #
由: Giovanni Musso, et al.
出版: (2008)

Pathogenesis and management issues for non-alcoholic fatty liver disease
由: Marko Duvnjak
出版: (2007)

Pathogenesis of non-alcoholic fatty liver disease
由: J. K. Dowman, et al.
出版: (2009)

Pathogenesis of non-alcoholic fatty liver disease
由: Dowman, J. K., et al.
出版: (2010)

Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates
由: Ullah, Rahim, et al.
出版: (2019)

An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatment.
由: Mouzaki, Marialena, et al.
出版: (2020)

Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates
由: Rahim Ullah, et al.
出版: (2019)

Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH
由: Giovanni Musso, et al.
出版: (2008)

Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
由: Saira Rafaqat, et al.
出版: (2024)

Non-alcoholic fatty liver disease: pathogenesis and models
由: Hanxiang Zhong
出版: (2024)

Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease
由: Giovanni Musso, et al.
出版: (2005)